Keystone Clinical Studies

Keystone Clinical Studies is an independent clinical research organization based in Plymouth Meeting, Pennsylvania. The company employs five people and generates annual revenue of $2.5 million. Keystone Clinical Studies specializes in conducting Phase 2, 3, and 4 clinical trials for a range of neuropsychiatric disorders. The company focuses on researching new medications for Alzheimer's disease, Parkinson's disease, and depression. Keystone Clinical Studies strives to improve the lives of patients, their families, and communities through its research efforts. Their commitment to improving the lives of individuals affected by these debilitating conditions is central to their mission. For more information, please visit Keystone Clinical Studies' website at keystoneclinicals.com.